We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs), intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is headquartered in Hyderabad, India.
TODAY'S HIGH
3679.45
TODAY'S LOW
3595.15
52 WEEK HIGH
5425.1
52 WEEK LOW
3365.55
% of Shares Held by
All Insider
52.36%
% of Shares Held by
Institutions
26.67%
% of Float Held by
Institutions
55.98%
Number of Institutions
Holding Shares
216
MARKET CAP
96618.76 Cr.
ETERPRISE VALUE
93751.50 Cr.
NO. OF SHARES
26.54 Cr.
BOOK VALUE
441.786
DIV. YIELD
20%
DEBT
3.69 Cr.
GROSS PROFIT
5992.69 Cr.
CASH
2818.87 Cr.
REVENUE
8959.82 Cr.
REVENUE/SHARE
337.516
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Investments | -1548.53 Cr. | 928.16 Cr. | 1056.29 Cr. | -42.95 Cr. |
| Change To Liabilities | 34.27 Cr. | 174.80 Cr. | 93.85 Cr. | 84.16 Cr. |
| Total cashflows from Investing Activities | -2194.92 Cr. | 75.13 Cr. | -83.47 Cr. | -685.40 Cr. |
| Net Borrowings | -1.14 Cr. | -34.02 Cr. | -61.20 Cr. | 77.60 Cr. |
| Total Cash from Financing Activities | -532.44 Cr. | -34.89 Cr. | -1091.42 Cr. | -245.94 Cr. |
| Other Liabilities | 20.29 Cr. | 107.89 Cr. | -13.93 Cr. | 23.15 Cr. |
| Total Assets | 0 | 0 | 0 | 0 |
| Net Income | 2960.45 Cr. | 1984.29 Cr. | 1376.54 Cr. | 1352.74 Cr. |
| Change in Cash | -815.56 Cr. | 1987.17 Cr. | 41.05 Cr. | 22.96 Cr. |
| Effect of Exchange Rate | 0 | 0 | 0 | 0 |
| Total Cash from Operating Activities | 1911.80 Cr. | 1946.93 Cr. | 1215.94 Cr. | 954.30 Cr. |
| Depreciation | 311.51 Cr. | 252.62 Cr. | 183.38 Cr. | 166.24 Cr. |
| Other Cashflows from Investing Activities | 66.81 Cr. | 57.01 Cr. | 43.09 Cr. | 90.60 Cr. |
| Dividends Paid | -530.94 Cr. | -530.94 Cr. | -849.50 Cr. | -265.47 Cr. |
| Change to Inventory | -683.39 Cr. | -281.37 Cr. | -91.52 Cr. | -421.67 Cr. |
| Change to Account Receivables | -741.62 Cr. | -265.40 Cr. | -206.70 Cr. | -185.48 Cr. |
| Other Cashflows from Financing Activities | -36 Lakhs | -87 Lakhs | -180.72 Cr. | -58.07 Cr. |
| Change to Net Income | 10.29 Cr. | -28.87 Cr. | -128.54 Cr. | -67.50 Cr. |
| Capital Expenditures | -713.20 Cr. | -910.19 Cr. | -1183.21 Cr. | -733.07 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Research Development | None | None | None | None |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | 3683.50 Cr. | 2666.04 Cr. | 1819.46 Cr. | 1855.07 Cr. |
| Minority Interest | None | None | None | None |
| Net Income | 3570.43 Cr. | 2614.76 Cr. | 1639.23 Cr. | 1708.63 Cr. |
| Selling General Administrative | 946.16 Cr. | 836.69 Cr. | 631.68 Cr. | 551.90 Cr. |
| Gross Profit | 5992.69 Cr. | 4497.65 Cr. | 3148.92 Cr. | 3022.19 Cr. |
| Ebit | 3570.43 Cr. | 2614.76 Cr. | 1639.23 Cr. | 1708.63 Cr. |
| Operating Income | 3570.43 Cr. | 2614.76 Cr. | 1639.23 Cr. | 1708.63 Cr. |
| Other Operating Expenses | 1164.59 Cr. | 790.61 Cr. | 691.77 Cr. | 592.14 Cr. |
| Interest Expense | -80 Lakhs | -39 Lakhs | -5.54 Cr. | -2.12 Cr. |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | 723.05 Cr. | 681.75 Cr. | 442.92 Cr. | 502.33 Cr. |
| Total Revenue | 8959.83 Cr. | 6969.47 Cr. | 5394.47 Cr. | 4946.27 Cr. |
| Total Operating Expenses | 5389.40 Cr. | 4354.71 Cr. | 3755.24 Cr. | 3237.64 Cr. |
| Cost of Revenue | 2967.14 Cr. | 2471.82 Cr. | 2245.55 Cr. | 1924.08 Cr. |
| Total Other Income Expense Net | 113.07 Cr. | 51.28 Cr. | 180.23 Cr. | 146.44 Cr. |
| Discontinued Operations | None | None | None | None |
| Net Income from Continuous Ops. | 2960.45 Cr. | 1984.29 Cr. | 1376.54 Cr. | 1352.74 Cr. |
| Net Income Applicable to Common Shares | 2960.45 Cr. | 1984.29 Cr. | 1376.54 Cr. | 1352.74 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Intangible Assets | 7.49 Cr. | 4.95 Cr. | 3.60 Cr. | 4.05 Cr. |
| Capital Surplus | 0 | 79.88 Cr. | 79.88 Cr. | 79.88 Cr. |
| Total Liabilities | 1646.53 Cr. | 1479.46 Cr. | 1225.78 Cr. | 1081.10 Cr. |
| Stock Holder Equity | 11728.18 Cr. | 9294.61 Cr. | 7309.92 Cr. | 6957.15 Cr. |
| Minority Interest | 0 | 0 | 0 | 0 |
| Other Liabilities | 394.88 Cr. | 99.55 Cr. | 112.82 Cr. | 74.32 Cr. |
| Total Assets | 13374.71 Cr. | 10774.07 Cr. | 8535.70 Cr. | 8038.25 Cr. |
| Common Stock | 53.09 Cr. | 53.09 Cr. | 53.09 Cr. | 53.09 Cr. |
| Retained Earnings | 0 | 9148.01 Cr. | 7163.56 Cr. | 6816.35 Cr. |
| Other Liabilities | 448.11 Cr. | 363.31 Cr. | 294.48 Cr. | 234.35 Cr. |
| Good Will | 0 | 0 | 0 | 0 |
| Treasury Stock | 11675.09 Cr. | 13.63 Cr. | 13.39 Cr. | 7.83 Cr. |
| Other Assets | 156.22 Cr. | 184.86 Cr. | 154.32 Cr. | 261.26 Cr. |
| Cash | 2818.88 Cr. | 2030.32 Cr. | 43.15 Cr. | 13 Cr. |
| Current Liabilities | 1195.55 Cr. | 1112.46 Cr. | 926.83 Cr. | 846.75 Cr. |
| Long Term Asset Charges | 14.47 Cr. | 3.23 Cr. | 4.38 Cr. | 2.34 Cr. |
| Short Long Term Debt | 0 | 0 | 0 | 0 |
| Other Stockholder Equity | 11675.09 Cr. | 13.63 Cr. | 13.39 Cr. | 7.83 Cr. |
| Property Plant Equipment | 4787.49 Cr. | 4409.54 Cr. | 3697.94 Cr. | 2575.63 Cr. |
| Total Cur. Assets | 8351.50 Cr. | 6174.71 Cr. | 4679.83 Cr. | 4650.05 Cr. |
| Long Term Investments | 72.01 Cr. | 1 Lakh | 1 Lakh | 547.26 Cr. |
| Net Tangible Assets | 11720.69 Cr. | 9289.66 Cr. | 7306.32 Cr. | 6953.10 Cr. |
| Short Term Investments | 0 | 54.64 Cr. | 11.01 Cr. | 0 |
| Net Receivables | 2423.88 Cr. | 1778.30 Cr. | 1599.04 Cr. | 1296.49 Cr. |
| Long Term Debt | 0 | 0 | 0 | 0 |
| Inventory | 2828.62 Cr. | 2145.23 Cr. | 1863.86 Cr. | 1772.34 Cr. |
| Accounts Payable | 795.70 Cr. | 763.20 Cr. | 590.72 Cr. | 492.26 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account